LAKEWOOD, Colo.--(BUSINESS WIRE)-- Terumo BCT has received clearance for the preparation of plasma held at 1° to 6° C within 8 hours and frozen within 24 hours after phlebotomy (PF24) and plasma held ...
In recent years, as many of the diseases for which allogeneic HPC transplantation is indicated are associated with advancing age; this therapy has been increasingly offered to patients in their sixth ...
Terumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia(R) Apheresis System at major conferences Lakewood, Colorado, US, May 25, 2023 – Terumo Blood and ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced today that the Spectra Optia system mononuclear cell (MNC) collection protocol is now cleared by the U.S. Food and Drug Administration (FDA) and ...
The company also welcomes new board member and industry expert Cyrus K. Mirsaidi in furthering Sanguine's mission to integrate patients into the therapeutic research and development process. WALTHAM, ...
Autologous peripheral SCT has largely replaced BMT for the treatment of cancer in both adults and children. Cells are collected by apheresis. The technique has been widely used in France since its ...
Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry. The optimal dose of granulocyte colony-stimulating factor (G-CSF) ...
SAN FRANCISCO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software and analytics company for cell and gene therapies, today announced that it will be expanding its technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results